The Bioavailability Barrier, Solved.
Our biomimetic fluid architectures thermodynamically stabilize volatile small molecules, preventing oxidative degradation to maximize systemic bioavailability and cellular uptake.
“
Nature designs the molecule; we bring together dynamic environments to enhance and precisely target molecular therapeutics to the cell.”
Dr. Brandie M Cross
Founder & CSO
PROBLEM: Biomolecular Fragility
Phytochemicals, polyphenols, and terpenes possess immense therapeutic potential but degrade instantly when exposed to light, oxygen, or gastric acid.
SOLUTION: Advanced Liquid Matrices
Our proprietary fluid technology integrates delicate active ingredients into a continuous, biocompatible liquid phase, preserving molecular integrity without relying on hard synthetic shells.
Stories
Latest in Community
Beyond the confines of traditional academia, our organization is deeply rooted in community development.
-
Hello World!
Welcome to WordPress! This is your first post. Edit or delete it to take the first step in your blogging journey.
TPLEX THERAPEUTICS 